Clinical Trials Logo

Filter by:
NCT ID: NCT05748795 Recruiting - Clinical trials for Microbial Colonization

Microbial Colonization in Lung Cancer Patients

Start date: February 1, 2023
Phase:
Study type: Observational [Patient Registry]

Primary Aim: -To determine the prevalence and pattern of bronchial colonization in patients presenting with lung cancer at the time of diagnosis Secondary Aim: -To assess the potential demographic, clinical, radiological and histological predictors of colonization in patients with lung cancer

NCT ID: NCT05748782 Recruiting - Airway Device Clinical Trials

BASKA Mask in Otologic Surgery in Lateral Position

BASKAvsETT
Start date: July 23, 2023
Phase:
Study type: Observational

This study aims to evaluate the Efficiency and safety of BASKA mask ventilation in comparison with endotracheal intubation during otologic surgery performed with the head and neck in the lateral position. The primary outcome will be the intraoperative peak inspiratory pressure (PIP). Secondary outcomes will be intraoperative lung mechanics, oropharyngeal leak pressure (OLP), ventilation score, fiberoptic glottic view score, and perioperative adverse effects.

NCT ID: NCT05748587 Recruiting - Brain Ischemia Clinical Trials

Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in Ischemic Stroke

Start date: April 1, 2023
Phase:
Study type: Observational

This observational study aims to detect levels of iron, alpha-synuclein, and soluble lymphocyte activation gene 3 in acute ischemic stroke patients. And to see expressions of iron, alpha-synuclein, and lymphocyte activation gene 3 in the brain tissue of ischemic rats. The main questions it aims to answer are: - Is there an association between iron and alpha-synuclein accumulation in ischemic stroke? - Is there any change in soluble lymphocyte activation gene levels in ischemic stroke and if these levels are related to stroke severity and infarction size? . Can soluble lymphocyte activation gene levels be used as an early biomarker to diagnose ischemic stroke?

NCT ID: NCT05746676 Recruiting - Clinical trials for Periodontal Diseases

Insulin Versus Hyaluronic Acid in Management of Periodontal Defects

Start date: January 12, 2023
Phase: Phase 3
Study type: Interventional

in this study, insulin and hyaluronic acid will be used after open flap debridement in treatment of periodontal defects. outcome will be evaluated clinically and radiographically

NCT ID: NCT05746598 Recruiting - Clinical trials for Non Small Cell Lung Cancer

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients

Start date: July 1, 2020
Phase:
Study type: Observational

Lung cancer is the leading cause of death worldwide, with non-small-cell lung cancer (NSCLC) being the most common histotype according to the global cancer observatory 2022. A variety of therapeutic options for advanced/metastatic non-oncogene-addicted NSCLC have recently been approved based on their impact on patient outcomes in terms of survival and safety profile. Current guidelines advocate for personalized treatment options based on molecular and immunologic characteristics, which drives the physician's decision toward tailored oncology. In the last two to three decades, hundreds of cancer biological prognostic markers for non-small cell lung cancer have been proposed. Although they have shown a potential in this field, validation studies are still required and, to date, there is in sufficient evidence to recommend the routine clinical use of any of these putative biomarkers. Therefore, the discovery of robust prognostic and/or predictive biomarkers in patients with non-small cell lung cancer is imperative for advancing treatment strategies for the disease and improving patient care.

NCT ID: NCT05746091 Recruiting - Orthopedic Disorder Clinical Trials

Arthroscopic Partial Trapezictomy With Hematoma Distraction in Basal Thumb Arthritis

Start date: December 30, 2023
Phase: N/A
Study type: Interventional

The basal joint, also referred to as the carpometacarpal (CMC) joint, of the thumb is one of the joints most commonly affected by arthritis. CMC joint arthritis can lead to decreased grip and pinch strength and impairment of activities of daily living

NCT ID: NCT05745935 Recruiting - Wound Heal Clinical Trials

Role of Local Skin Incision Infiltration by Oxytocin On Wound Healing

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

caesarean section rate in Egypt has reached about 60% between primgravidae. Wound complications are of the most common morbidities following cesarean section. The prevalence of wound infection and disruption after cesarean has been reported as 3-15%, averagely speaking 6% and 2-42% in various studies. These complications affect mother's quality of life due to stress, anxiety, delay in mother's ability and health recovery

NCT ID: NCT05744349 Recruiting - Fracture Forearm Clinical Trials

Percutaneous Intramedullary K-wires Fixation of Pediatric Shaft Both Bone Forearm Fractures

Start date: February 28, 2023
Phase: N/A
Study type: Interventional

This study is to improving outcome of pediatric both bone forearm fractures using minimally invasive procedure by intramedullary K-wires.

NCT ID: NCT05742399 Recruiting - Wrinkle Clinical Trials

Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles

Start date: December 21, 2022
Phase: N/A
Study type: Interventional

In this study, The investigators aims to evaluate the efficacy and safety of topical hyaluronic acid nanoparticles as a novel nanodermatological tool in periocular rejuvenation as a replacement approach of invasive dermal filler injections.

NCT ID: NCT05741697 Recruiting - Bronchiectasis Clinical Trials

HFNC in Management of Bronchiectasis Exacerbation

Start date: March 1, 2023
Phase:
Study type: Observational

Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).